Centrum Kliniczno-Badawcze

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Obstructive sleep apnoea1 trial
• Osteoarthritis1 trial
• Peripheral artery disease1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Rheumatoid arthritis1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Janssen Research & Development, LLC1 trial
• Kiniksa Pharmaceuticals, Ltd.1 trial

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Eli Lilly and Company· Source

• Completed

  Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

  NCT05198310· Phase 2· Kiniksa Pharmaceuticals, Ltd.· Source

• Completed

  A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

  NCT05071664· Phase 2· Janssen Research & Development, LLC· Source